Antibodies targeting enzyme inhibition as potential tools for research and drug development

Abstract

Antibodies have transformed biomedical research and are now being used for different experimental applications. Generally, the interaction of enzymes with their specific antibodies can lead to a reduction in their enzymatic activity. The effect of the antibody is dependent on its narrow i.e. the regions of the enzyme to which it is directed. The mechanism of this inhibition is rarely a direct combination of the antibodies with the catalytic site, but is rather due to steric hindrance, barring the substrate access to the active site. In several systems, however, the interaction with the antibody induces conformational changes on the enzyme that can either inhibit or enhance its catalytic activity. The extent of enzyme inhibition or enhancement is, therefore, a reflection of the nature and distribution of the various antigenic determinants on the enzyme molecule. Currently, the mode of action of many enzymes has been elucidated at the molecular level. We here review the molecular mechanisms and recent trends by which antibodies inhibit the catalytic activity of enzymes and provide examples of how specific antibodies can be useful for the neutralization of biologically active molecules

Antimicrobial Resistance in the COVID-19 Landscape: Is There an Opportunity for Anti-Infective Antibodies and Antimicrobial Peptides?

“…Proteins on microbe surfaces, toxins, and other virulence factors can all be targets for antibodies. Enzyme areas crucial for microbial metabolism can also be targeted by antibody design, being able to influence the activity of antigen molecules without necessarily affecting the immune response (105).…”

Translational aspect in peptide drug discovery and development: An emerging therapeutic candidate

“…Determination of the clinical dose range can be greatly facilitated by this method. 69 Biologics, particularly antibodies, are generally superior to peptides in terms of pharmacokinetics, 70,71 but may also offer other advantages, including ease of manufacture, targeting of key enzymes 72 and reduced activation of immune responses over time. 73 6.…”

“…Determination of the clinical dose range can be greatly facilitated by this method 69 . Biologics, particularly antibodies, are generally superior to peptides in terms of pharmacokinetics, 70,71 but may also offer other advantages, including ease of manufacture, targeting of key enzymes 72 and reduced activation of immune responses over time 73 Finally, it is important to consider the manufacturing costs of peptides and the purification procedures of high‐performance liquid chromatography, which are still relatively high compared with small molecules, although they continue to decrease with advances.…”

Natural Antibodies Produced in Vaccinated Patients and COVID-19 Convalescents Recognize and Hydrolyze Oligopeptides Corresponding to the S-Protein of SARS-CoV-2

“…The primary physiological function of antibodies is to recognize and eliminate the antigen. However, antibodies are also capable of catalyzing specific chemical reactions [ 13 , 14 , 15 ]. Natural catalytic antibodies have been found in a variety of physiological and pathological conditions, including viral infections and autoimmune diseases [ 16 , 17 , 18 , 19 ].…”